Skip to content
10-Q

Quarterly Report

POINT BIOPHARMA GLOBAL INC.

0001811764-23-000038

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 9, 2023 105.77M sh
Shares Diluted Q2 2023 · Jun 30, 2023 105.72M sh
Shares Diluted Q2 2023 · Jun 30, 2023 105.69M sh
Shares Diluted Q2 2023 · Jun 30, 2022 90.12M sh
Shares Diluted Q2 2023 · Jun 30, 2022 90.12M sh
Dividends Paid Q2 2023 · Jun 30, 2023 $0
Dividends Paid Q2 2023 · Jun 30, 2023 $0
Dividends Paid Q2 2023 · Jun 30, 2022 $0
Capex Q2 2023 · Jun 30, 2023 $10.86M
Capex Q2 2023 · Jun 30, 2022 $3.08M
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$96.73M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$31.07M
Short Term Investments Q2 2023 · Jun 30, 2023 $365.93M
Short Term Investments Q2 2023 · Dec 31, 2022 $238.78M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $57.29M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $286.43M
Current Liabilities Q2 2023 · Jun 30, 2023 $41.16M
Current Liabilities Q2 2023 · Dec 31, 2022 $79.74M
Total Liabilities Q2 2023 · Jun 30, 2023 $50.32M
Total Liabilities Q2 2023 · Dec 31, 2022 $91.37M
Current Assets Q2 2023 · Jun 30, 2023 $432.38M
Current Assets Q2 2023 · Dec 31, 2022 $530.82M
Total Assets Q2 2023 · Jun 30, 2023 $497.77M
Total Assets Q2 2023 · Dec 31, 2022 $578.32M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.24
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.40
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.27
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.45
Eps Basic Q2 2023 · Jun 30, 2023 −$0.24
Eps Basic Q2 2023 · Jun 30, 2023 −$0.40
Eps Basic Q2 2023 · Jun 30, 2022 −$0.27
Eps Basic Q2 2023 · Jun 30, 2022 −$0.45
Sga Expense Q2 2023 · Jun 30, 2023 $5.09M
Sga Expense Q2 2023 · Jun 30, 2023 $10.1M
Sga Expense Q2 2023 · Jun 30, 2022 $4.08M
Sga Expense Q2 2023 · Jun 30, 2022 $7.89M
Rd Expense Q2 2023 · Jun 30, 2023 $31.28M
Rd Expense Q2 2023 · Jun 30, 2023 $58.19M
Rd Expense Q2 2023 · Jun 30, 2022 $20.81M
Rd Expense Q2 2023 · Jun 30, 2022 $33.31M
Net Income Q2 2023 · Jun 30, 2023 −$25.41M
Net Income Q2 2023 · Jun 30, 2023 −$41.94M
Net Income Q2 2023 · Mar 31, 2023 −$16.53M
Net Income Q2 2023 · Jun 30, 2022 −$24.58M
Net Income Q2 2023 · Jun 30, 2022 −$40.96M
Net Income Q2 2023 · Mar 31, 2022 −$16.38M
Operating Income Q2 2023 · Jun 30, 2023 −$31.5M
Operating Income Q2 2023 · Jun 30, 2023 −$53.96M
Operating Income Q2 2023 · Jun 30, 2022 −$24.89M
Operating Income Q2 2023 · Jun 30, 2022 −$41.2M
Revenue Q2 2023 · Jun 30, 2023 $4.87M
Revenue Q2 2023 · Jun 30, 2023 $14.32M
Revenue Q2 2023 · Jun 30, 2022 $0
Revenue Q2 2023 · Jun 30, 2022 $0